The invention relates to an arrangement for use with a medical device.
The invention can be implemented in various medical equipments and be used for a number of purposes, but hereinafter the particular, but not in no way limiting for the invention, fields of application constituting an arrangement used together with a device for aseptic preparation of drugs will be described.
In the field of drug preparation for injection or infusion generally two basic problems have to be considered. Firstly, certain demands are made on aseptic conditions so as to avoid contamination of the drug, and, secondly, the drug has to be handled in such a way that drug leakage to the environment is prevented or minimized. By a sterile or aseptic handling of the drug, the risk for transferring bacteria or any other undesired substance to the patient is reduced. By preventing drug leakage to the environment, the exposure of medical and pharmacological staff to hazardous drugs is decreased.
In order to achieve aseptic conditions special safety boxes, cabinets or isolators are being used where the air is filtered through HEPA filters to prevent contamination during preparation of drugs. Ventilated cabinets are also used to reduce uncontrolled leakage to the environment and prevent occupational exposure to possibly hazardous drugs. Such facilities, however, require a lot of space and are associated with relatively high costs. Furthermore, the offered protection can be insufficient and working environment problems due to accidental exposure to drugs, for example cytotoxins, have been reported.
Another solution of the problems mentioned above is to create a so called “closed” or “non-vented” system for handling the drugs during preparation. Such systems exist and enable the preparation to be accomplished without the use of special clean rooms or fume cupboards. In such a closed system the drugs are handled isolated from the environment during every single step so as to avoid contamination of the drug and undesired drug leakage to the environment.
A known problem associated with the preparation of drug solutions is the fact that medical bottles or vials normally are made of a non-compressible material, such as glass or plastic. To enable the vial to be drained off, air has to flow into the vial so as to avoid negative pressure in the drug vial which negative pressure otherwise counteracts or prevents further transportation of liquid from the vial to another receptacle such as syringe.
Different systems for providing sterilised or cleaned gas are described for example in WO 00/35517 and WO 02/11794. However, these systems have drawbacks due to the number of manipulations to be accomplished and/or the requisite special equipment for providing the gas.
Within the field of medical devices very often any kind of needle for penetration is used. For example, hollow needles are used for penetration of a closing (which can be made of rubber for instance) covering an opening of a drug vial. Such injection needles or cannulae can be used for enabling gas or liquid transportation between a drug vial and another receptacle. The expression “piercing member” or “needle” used hereinafter is meant to comprise also spikes and similar components for penetration of such a closing in order to create a channel for the transportation of gas or liquid.
A medical device comprising such a needle has drawbacks because the person handling the device can due to incautiousness be injured by the needle. Furthermore, the package enclosing the device can be damaged by the needle during transport and storage of the device. To solve this problem such medical devices can be provided with a needle shield covering the tip of the needle, which shield functions as a protection during storage and the initial handling of the device.
An object of the invention is to provide an arrangement for use with a medical device, which arrangement can reduce the total number of requisite components and/or provide an additional function to a medical device. In particular, the invention aims to provide such an arrangement suitable for use together with a medical device for providing cleaned gas in a rational and safe way during preparation of drugs.
According to the invention the object is achieved by an arrangement according to claim 1.
By the provision of an arrangement which comprises a shield for a tip of a needle member of a medical device, wherein the arrangement comprises a filter, preferably a particulate air filter for filtering gas to be transferred out from or into the medical device via the needle member when the arrangement is interconnected with the medical device, and the filter is integrated with or constitutes at least a portion of the needle member tip shield, two important functions are provided in one single component. The needle member tip is protected or shielded and gas can be cleaned by means of the filter. Thus, the invention is based on the insight that by providing a needle member tip shield with a filter two functions can be achieved in one and the same component.
According to a preferred embodiment of the invention the needle member tip shield is mainly or entirely constituted by the filter. By manufacturing the needle shield from a filter material a single component having two functions can be obtained in a very rational way.
Further advantages and advantageous features of the arrangement according to the invention are disclosed in the following description and remaining dependent claims.
The invention also relates to a medical device provided with a needle member and an arrangement according to the invention.
With reference to the appended drawings, below follows a more detailed description of preferred embodiments of the invention cited as examples.
In the drawings:
b is a cross section view illustrating a portion of a filter having a channel for receiving a needle member,
In
The first connection means 5′ can be designed for connection to a bottle, such as the neck of a vial. In the embodiment illustrated in
In another embodiment the second connection means 12′ can comprise a luer lock coupling or bayonet coupling (not shown) to enable an injection device to be connected. Both the injector device and the connector are suitably provided with a membrane so as to create a double membrane coupling between the injector and the current device.
The connector 2′ is preferably provided with a piercing member, such as a hollow needle 14′ (as illustrated) for penetration of a closing (not illustrated) made of rubber for instance, which closing covers the opening of a receptacle 6, such as vial. In addition to injection needles or cannulae, the expression “needle” is meant to comprise spikes and similar components for penetration of such a closing in order to create a channel for transportation of gas. Herein, a channel between the container 3′ and the receptacle 6′ to which the connector 2′ is connected is created. By a channel or passage 15′ of the needle 14′, gas contained in the container 3′ can be transferred from the container to the receptacle 6′, i.e. gas can flow from the container 3′ to the receptacle 6′.
The connector 2′ and the container 3′ may form an integrated unit 4′. This implies that the connector and the container are made in one piece or the connector 2′ and the container 3′ can be coupled to each other so as to form an integral unit. For such a reason, different types of coupling means 16′ known from prior art can be used as long as an airtight, or at least a substantially airtight connection can be obtained between the current components 2′, 3′.
The container 3′ has to be filled with gas before connection of the connector 2′ to a receptacle 6′. The volume of the container 3′ is preferably variable. To obtain a container 3′ having a variable volume the container can comprise a first portion 17′ made by a relatively rigid material which first portion is coupled to the connector 2′, and a second portion 18′ made by a relatively flexible material attached to the first portion 17′. The second portion 18′ can be extensible by manipulation of for example a handle 20′ arranged at the end of the container 3′. Hereby the volume of the container 3′ can be increased and decreased, respectively. For example, the container 3′ can be designed as a bellow which is compressible and extendable by affecting the container manually. The container 3′ is preferably provided with said handle 20′ for regulating the volume of the container 3′. Although the volume of the container is preferably variable as illustrated, there may be other ways to fill the container and at the same time ensure that the gas passes a filter 21′. For example, the gas container could be constituted by a sealed vacuum-packed flexible bag whose seal can be broken to allow gas to flow into the bag.
Alternatively, the gas container is rigid or semi-rigid and pressurized gas is used to fill the container.
The amount of gas, preferably air, provided by the pre-filled container, should be adapted to the volume of the receptacle which is to be drained off. The volume of the gas when being in the receptacle should preferably correspond to the volume of the receptacle so as to enable the receptacle to be completely drained off. This implies that the volume of the cleaned or sterilized gas in the pre-filled container is preferably approximately equal to or larger than the volume of the receptacle provided that the pressure of the gas is substantially the same in the receptacle as in the container. For most medicine bottles or vials, the volume of the gas should be in the interval 1-100 cm3 at atmospheric pressure.
By the expression “cleaned” gas is meant that the gas has been filtered by a filter, such as a particulate air filter to remove particles and/or viable micro-organisms to such an extent that the gas is classified to be aseptic and accepted by the relevant authority and/or any standards. The degree of purity can be expressed in the largest particles allowed to pass the filter for a given flow rate of gas. In some cases no or very few particles having a size exceeding 5 μm are allowed to occur in the cleaned gas. However, the allowed particle size is determined by the requirements in the current application. Some drug treatments require that substantially all particles having a size exceeding 0.15 μm are removed from the gas by the particulate air filter. As an example, a filter with the mesh size 0.2 μm can be used to remove substantially all particles and micro organisms of that size.
Furthermore, the medical device 1′ is provided with an arrangement 30′ according to the invention. The arrangement 30′ and the medical device 1′ are interconnected with each other. In the embodiment illustrated in
In a preferred embodiment of the invention the needle member tip shield is adapted to be arranged to at least partially cover or surround the tip of a needle member of a medical device when the arrangement is interconnected with the medical device. This implies that the needle member tip shield covers the tip at least in one direction so as to avoid a user of the arrangement to be injured by the needle due to incautiousness. For example, the shield can be arranged immediately in front of the tip so as to cover the tip in the longitudinal direction of the needle member. The shield can also be designed as a tube, or as a part or parts of a tube, which surrounds the needle tip. Such a shield rather covers the tip in a direction substantially perpendicular to the longitudinal direction of the needle member but extends beyond the tip in the longitudinal direction of the needle and away from the needle member so as to prevent contact with the needle member tip also in the longitudinal direction.
The particulate air filter 21′ is preferably adapted to be arranged in front of the tip 23′ of the needle member 14′ and to at least partially cover or surround the tip of the needle member 14′ of the medical device when the arrangement is interconnected with the medical device. As already described, the particulate air filter 21′ may be arranged in a frame or holder 24′ or similar which in turn fits to the connector 2′. Furthermore, alternatively or in combination, the air particulate filter 21′ itself can be designed to be engaged with the connector 2′ and/or with the needle member 14′, or the particulate air filter 21′ can be partly penetrated by the needle member 14′ so as to keep the particulate air filter 21′ in position. Thus, in one embodiment of the invention the particulate air filter 21′ is adapted to be arranged to enclose the tip 23′ of the needle member 14′ of the medical device 1′ when the arrangement 30′ is interconnected with the medical device 1′.
Instead of being partly penetrated by the needle 14′, the particulate air filter 21′ can be provided with a channel 31′ (illustrated in
In accordance with a preferred embodiment of the invention the particulate air filter 21′ is designed and arranged as a protection portion of the needle member shield 22′. This implies that the particulate air filter 21′ cleans the gas and at the same time the particulate air filter 21′ functions as a protection during handling of the device 1′, since the particulate air filter 21′ at least partially covers or surround the tip 23′ of the needle 14′. Furthermore, the needle member tip shield 22′ protects the sterile package enclosing the device during transport and storage of the device.
The particulate air filter 21′ is preferably arranged to abut against the needle member tip 23′, or rather in immediate contact with the needle portion having an opening 32′ for fluid transportation into or out from the needle member 14′. By covering the opening 32′ of the needle 14′ by means of the particulate air filter 21′, it is ensured that the gas which is brought into the container 3′ has to pass the particulate air filter 21′. The arrangement and thus the needle member tip shield 22′ is preferably adapted to be removably arranged on a medical device 1′. In the illustrated examples the needle member shield 22′ is removed before connection of the medical device 1′ to a vial 6′ as further described hereinafter. The arrangement 30′ according to the invention, and, thus the particulate air filter 21′ is arranged to be removed from the integrated unit 4′ after the container 3′ has been filled with cleaned gas. Subsequently to filling the container 3′ the particulate air filter 21′ is removed and the connector 2′ is to be connected to the receptacle 6′. By removing the particulate air filter 21′, after the container 3′ has been filled with the gas and prior to interconnection of the connector 2′ and the receptacle 6′ to each other, any contamination particles removed from the gas and collected in the particulate air filter 21′ are removed from the integrated unit 4′. Thus, one and the same channel 15′ can be used for both filling the container 3′ with cleaned gas and transferring the cleaned gas from the container 3′ to a receptacle 6′.
In
A cover means, for example a lid (not illustrated) can be arranged for covering the particulate air filter, preferably in an airtight manner. The lid may have the function of preventing transportation of liquid, gas or any vapour in the direction from the medical device to the environment or in the opposite direction, i.e. into the medical device from the environment, so as to counteract that any undesired substance in the receptacle escapes to the environment or is introduced into the medical device, respectively.
Such a lid can be used to prevent further communication between the interior of the medical device and the environment via the particulate air filter after the container has been filled. The container can be filled with the cleaned gas and thereafter the lid is mounted to cover the particulate air filter and prevent further gas transportation through the air particle filter. Thereafter, the arrangement can be removed from the medical device and the connector and the receptacle can be interconnected, and the subsequent manipulations can be safely executed.
It is to be understood that the present invention is not limited to the embodiments described above and illustrated in the drawings; rather, the skilled person will recognize that many changes and modifications may be made within the scope of the appended claims.
Number | Name | Date | Kind |
---|---|---|---|
1844342 | Berman | Feb 1932 | A |
2010417 | Schwab | Aug 1935 | A |
2697438 | Hickey | Dec 1954 | A |
2717599 | Huber | Sep 1955 | A |
3064651 | Henderson | Nov 1962 | A |
3071135 | Baldwin et al. | Jan 1963 | A |
3308822 | DeLuca | Mar 1967 | A |
3316908 | Burke | May 1967 | A |
3340671 | Loo | Sep 1967 | A |
3390677 | Razimbaud | Jul 1968 | A |
3448740 | Figge | Jun 1969 | A |
3542240 | Solowey | Nov 1970 | A |
3783895 | Weichselbaum | Jan 1974 | A |
3788320 | Dye | Jan 1974 | A |
3822700 | Pennington | Jul 1974 | A |
3938520 | Scislowicz et al. | Feb 1976 | A |
3976073 | Quick et al. | Aug 1976 | A |
4096860 | McLaughlin | Jun 1978 | A |
4296786 | Brignola | Oct 1981 | A |
D270568 | Armstrong | Sep 1983 | S |
4490139 | Huizenga et al. | Dec 1984 | A |
4507118 | Dent | Mar 1985 | A |
4516967 | Kopfer | May 1985 | A |
4524809 | Dent | Jun 1985 | A |
4564054 | Gustavsson | Jan 1986 | A |
4573967 | Hargrove et al. | Mar 1986 | A |
4576211 | Valentini et al. | Mar 1986 | A |
4581016 | Gettig | Apr 1986 | A |
4582223 | Kobe | Apr 1986 | A |
4588403 | Weiss et al. | May 1986 | A |
4600040 | Naslund | Jul 1986 | A |
4623343 | Thompson | Nov 1986 | A |
4629455 | Kanno | Dec 1986 | A |
4632673 | Tiitola et al. | Dec 1986 | A |
4636204 | Christopherson et al. | Jan 1987 | A |
4673400 | Martin | Jun 1987 | A |
4673404 | Gustavsson | Jun 1987 | A |
4737150 | Baeumle et al. | Apr 1988 | A |
4752287 | Kurtz et al. | Jun 1988 | A |
4768568 | Fournier et al. | Sep 1988 | A |
4792329 | Schreuder | Dec 1988 | A |
4804015 | Albinsson | Feb 1989 | A |
4822340 | Kamstra | Apr 1989 | A |
4826492 | Magasi | May 1989 | A |
4834717 | Haber et al. | May 1989 | A |
4842585 | Witt | Jun 1989 | A |
4850978 | Dudar et al. | Jul 1989 | A |
4864717 | Baus, Jr. | Sep 1989 | A |
4872494 | Coccia | Oct 1989 | A |
4878897 | Katzin | Nov 1989 | A |
4889529 | Haindl | Dec 1989 | A |
4898209 | Zbed | Feb 1990 | A |
4909290 | Coccia | Mar 1990 | A |
4932937 | Gustavsson et al. | Jun 1990 | A |
4944736 | Holtz | Jul 1990 | A |
4964855 | Todd et al. | Oct 1990 | A |
4982769 | Fournier et al. | Jan 1991 | A |
4994048 | Metzger | Feb 1991 | A |
4997083 | Loretti et al. | Mar 1991 | A |
5017186 | Arnold | May 1991 | A |
5041105 | D'Alo et al. | Aug 1991 | A |
5061264 | Scarrow | Oct 1991 | A |
5071413 | Utterberg | Dec 1991 | A |
5122116 | Kriesel et al. | Jun 1992 | A |
5122123 | Vaillancourt | Jun 1992 | A |
5137524 | Lynn et al. | Aug 1992 | A |
5147309 | Hemmerich et al. | Sep 1992 | A |
5158554 | Jepson et al. | Oct 1992 | A |
5176673 | Marrucchi | Jan 1993 | A |
5199947 | Lopez et al. | Apr 1993 | A |
5201725 | Kling | Apr 1993 | A |
5207658 | Rosen et al. | May 1993 | A |
5232109 | Tirrell et al. | Aug 1993 | A |
5254097 | Schock et al. | Oct 1993 | A |
5279576 | Loo et al. | Jan 1994 | A |
5279583 | Shober, Jr. et al. | Jan 1994 | A |
5279605 | Karrasch et al. | Jan 1994 | A |
5308347 | Sunago et al. | May 1994 | A |
5312366 | Vailancourt | May 1994 | A |
5328480 | Melker et al. | Jul 1994 | A |
5334163 | Sinnett | Aug 1994 | A |
5356406 | Schraga | Oct 1994 | A |
5385545 | Kriesel et al. | Jan 1995 | A |
5385547 | Wong et al. | Jan 1995 | A |
5389085 | D'Alessio et al. | Feb 1995 | A |
5405326 | Haber et al. | Apr 1995 | A |
5445630 | Richmond | Aug 1995 | A |
5447501 | Karlsson et al. | Sep 1995 | A |
5456675 | Wolbring et al. | Oct 1995 | A |
5470522 | Thome et al. | Nov 1995 | A |
5478328 | Silverman et al. | Dec 1995 | A |
5478337 | Okamoto et al. | Dec 1995 | A |
5492531 | Post et al. | Feb 1996 | A |
5514117 | Lynn | May 1996 | A |
5515871 | Bittner et al. | May 1996 | A |
5536259 | Utterberg | Jul 1996 | A |
5575780 | Saito | Nov 1996 | A |
5593028 | Haber et al. | Jan 1997 | A |
5613954 | Nelson et al. | Mar 1997 | A |
5632735 | Wyatt et al. | May 1997 | A |
5647845 | Haber et al. | Jul 1997 | A |
5685866 | Lopez | Nov 1997 | A |
5752942 | Doyle et al. | May 1998 | A |
5766147 | Sancoff et al. | Jun 1998 | A |
5766211 | Wood et al. | Jun 1998 | A |
5782383 | Robinson | Jul 1998 | A |
5782872 | Muller | Jul 1998 | A |
5795336 | Romano et al. | Aug 1998 | A |
5817083 | Shemesh et al. | Oct 1998 | A |
5820609 | Saito | Oct 1998 | A |
5827262 | Neftel et al. | Oct 1998 | A |
5837262 | Golubev et al. | Nov 1998 | A |
5875931 | Py | Mar 1999 | A |
5879345 | Aneas | Mar 1999 | A |
5897526 | Vaillancourt | Apr 1999 | A |
5934510 | Anderson | Aug 1999 | A |
5984899 | D'Alessio et al. | Nov 1999 | A |
6063068 | Fowles et al. | May 2000 | A |
D427308 | Zinger | Jun 2000 | S |
6070623 | Aneas | Jun 2000 | A |
6071270 | Fowles et al. | Jun 2000 | A |
6090091 | Fowles et al. | Jul 2000 | A |
6113068 | Ryan | Sep 2000 | A |
6113583 | Fowles et al. | Sep 2000 | A |
6142446 | Leinsing | Nov 2000 | A |
6146362 | Turnbull et al. | Nov 2000 | A |
6171293 | Rowley et al. | Jan 2001 | B1 |
6209738 | Jansen et al. | Apr 2001 | B1 |
6221065 | Davis | Apr 2001 | B1 |
6245056 | Walker et al. | Jun 2001 | B1 |
D445501 | Niedospial, Jr. | Jul 2001 | S |
6253804 | Safabash | Jul 2001 | B1 |
6258078 | Thilly | Jul 2001 | B1 |
6280430 | Neftel et al. | Aug 2001 | B1 |
6387074 | Horppu et al. | May 2002 | B1 |
6453956 | Safabash | Sep 2002 | B2 |
6471674 | Emig et al. | Oct 2002 | B1 |
6517523 | Kaneko et al. | Feb 2003 | B1 |
6537263 | Aneas | Mar 2003 | B1 |
6571837 | Jansen et al. | Jun 2003 | B2 |
6591876 | Safabash | Jul 2003 | B2 |
6644367 | Savage et al. | Nov 2003 | B1 |
6685692 | Fathallah | Feb 2004 | B2 |
6715520 | Andreasson et al. | Apr 2004 | B2 |
6761286 | Py et al. | Jul 2004 | B2 |
D495416 | Dimeo et al. | Aug 2004 | S |
6786244 | Jones | Sep 2004 | B1 |
D506256 | Miyoshi et al. | Jun 2005 | S |
6960194 | Hommann et al. | Nov 2005 | B2 |
7000806 | Py et al. | Feb 2006 | B2 |
7080672 | Fournier et al. | Jul 2006 | B2 |
7297140 | Orlu et al. | Nov 2007 | B2 |
D570477 | Gallogly et al. | Jun 2008 | S |
D572820 | Gallogly et al. | Jul 2008 | S |
D577438 | Gallogly et al. | Sep 2008 | S |
D577822 | Gallogly et al. | Sep 2008 | S |
D582033 | Baxter et al. | Dec 2008 | S |
D605755 | Baxter et al. | Dec 2009 | S |
7703486 | Costanzo | Apr 2010 | B2 |
D616984 | Gilboa | Jun 2010 | S |
7744581 | Wallen et al. | Jun 2010 | B2 |
20010021825 | Becker et al. | Sep 2001 | A1 |
20010025671 | Safabash | Oct 2001 | A1 |
20020002352 | Becker et al. | Jan 2002 | A1 |
20020082586 | Finley et al. | Jun 2002 | A1 |
20020127150 | Sasso | Sep 2002 | A1 |
20020177819 | Barker et al. | Nov 2002 | A1 |
20030010717 | Brugger et al. | Jan 2003 | A1 |
20030070726 | Andreasson et al. | Apr 2003 | A1 |
20030106610 | Roos et al. | Jun 2003 | A1 |
20030107628 | Fowles et al. | Jun 2003 | A1 |
20030199846 | Fowles et al. | Oct 2003 | A1 |
20030233083 | Houwaert et al. | Dec 2003 | A1 |
20040116858 | Heinz et al. | Jun 2004 | A1 |
20040199139 | Fowles et al. | Oct 2004 | A1 |
20040215147 | Wessman et al. | Oct 2004 | A1 |
20040267228 | Hattori et al. | Dec 2004 | A1 |
20050215977 | Uschold | Sep 2005 | A1 |
20060025747 | Sullivan et al. | Feb 2006 | A1 |
20060106360 | Wong | May 2006 | A1 |
20060111667 | Matsuura et al. | May 2006 | A1 |
20060157984 | Rome et al. | Jul 2006 | A1 |
20060186045 | Jensen et al. | Aug 2006 | A1 |
20070021725 | Villette | Jan 2007 | A1 |
20070060841 | Henshaw | Mar 2007 | A1 |
20070088313 | Zinger et al. | Apr 2007 | A1 |
20070106244 | Mosler et al. | May 2007 | A1 |
20070179441 | Chevallier | Aug 2007 | A1 |
20070270759 | Pessin | Nov 2007 | A1 |
20070270778 | Zinger et al. | Nov 2007 | A9 |
20080045919 | Jakob et al. | Feb 2008 | A1 |
20080103453 | Liversidge | May 2008 | A1 |
20080103485 | Kruger | May 2008 | A1 |
20080172039 | Raines | Jul 2008 | A1 |
20080223484 | Horppu | Sep 2008 | A1 |
20080287920 | Fangrow et al. | Nov 2008 | A1 |
20080312634 | Helmerson et al. | Dec 2008 | A1 |
20090254042 | Gratwohl et al. | Oct 2009 | A1 |
20100137827 | Warren et al. | Jun 2010 | A1 |
20100204671 | Kraushaar et al. | Aug 2010 | A1 |
20100243099 | Yodfat | Sep 2010 | A1 |
Number | Date | Country |
---|---|---|
200112863 | May 2003 | AU |
2005519 | Oct 1979 | DE |
0255025 | Feb 1988 | EP |
0259582 | Mar 1988 | EP |
0285424 | Oct 1988 | EP |
0311787 | Apr 1989 | EP |
0376629 | Jul 1990 | EP |
0803267 | Oct 1997 | EP |
0819442 | Jan 1998 | EP |
0995453 | Apr 2000 | EP |
1060730 | Dec 2000 | EP |
1484073 | Dec 2004 | EP |
1731128 | Dec 2006 | EP |
2757405 | Jun 1998 | FR |
2780878 | Jan 2000 | FR |
1579065 | Nov 1980 | GB |
49-12690 | May 1972 | JP |
62189072 | Aug 1987 | JP |
288664 | Jul 1990 | JP |
3030963 | Aug 1996 | JP |
2000167022 | Jun 2000 | JP |
2001505092 | Apr 2001 | JP |
2001293085 | Oct 2001 | JP |
482670 | Apr 2002 | TW |
WO 8404672 | Dec 1984 | WO |
WO 8404673 | Dec 1984 | WO |
WO 9003536 | Apr 1990 | WO |
WO 9819724 | May 1998 | WO |
WO 9927886 | Jun 1999 | WO |
WO 9962578 | Dec 1999 | WO |
WO 0005292 | Feb 2000 | WO |
WO 0035517 | Jun 2000 | WO |
WO0035517 | Jun 2000 | WO |
WO 0180928 | Nov 2001 | WO |
WO 0202048 | Jan 2002 | WO |
WO 0211794 | Feb 2002 | WO |
WO 02064077 | Aug 2002 | WO |
WO 02076540 | Oct 2002 | WO |
WO 2005074860 | Aug 2005 | WO |
WO 2006082350 | Aug 2006 | WO |
WO 2006083333 | Aug 2006 | WO |
WO 2006138184 | Dec 2006 | WO |
WO 2008115102 | Sep 2008 | WO |
Entry |
---|
Taiwan Search Report for Taiwan Patent Application 092106323,dated Mar. 21, 2003 (4 pages). |
Japan Application No. 2003-583539; Official Action dated May 1, 2009 (3 pages). |
Japan Application No. 2003-577789, Official Action dated Feb. 24, 2009 (4 pages). |
International Search Report, PCT/EP2008/067535 dated Oct. 13, 2009 (3 pages). |
International Search Report, PCT/EP2008/067522 dated Aug. 12, 2009. (2 pages). |
United States Patent Office, Final Office Action, U.S. Appl. No. 11/762,550, mailed Mar. 17, 2010 (11 pages). |
United States Patent Office, Non-Final Office Action, U.S. Appl. No. 11/762,550, mailed Jun. 12, 2009, (11 pages). |
Number | Date | Country | |
---|---|---|---|
20080312633 A1 | Dec 2008 | US |